CanVirex
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Malzgasse 9, Basel, Basel-City, 4052, Sw...Website
www.canvirex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About CanVirex
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CanVirex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on CanVirex recently announced quarterly report
Check out if CanVirex is spiking on competitors!
Click to see if CanVirex had a recent Job posting/layoffs
Product Launch: Get notified when CanVirex launches new products
CanVirex, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CanVirex has new funding data
Check if CanVirex has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CanVirex
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at CanVirex
Find more new buyers
Company Profile Activity
Activity Insights
CanVirex is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CanVirex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CanVirex.
CanVirex Tech Stack
A closer look at the technologies used by CanVirex
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding CanVirex
CanVirex is a spin-off from Heidelberg University Hospital focused on developing next-generation measles viruses for cancer immunotherapy. Their platform technology utilizes genetically modified measles viruses to selectively target cancer cells and deliver therapeutic genetic material. The company aims to provide personalized treatment approaches... Read More
